Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2005 | 09-2004 | 09-2003 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 372,608 | 78,711 | N/A |
| Receivables | 33,242 | 24,430 | N/A |
| Inventories | 11,722 | 7,163 | N/A |
| Income taxes - deferred | 31,183 | 30,813 | N/A |
| TOTAL | $454,188 | $144,757 | $N/A |
| Non-Current Assets | |||
| PPE Net | 76,462 | 72,333 | N/A |
| Investments And Advances | 0 | 244 | 0 |
| Intangibles | 41,049 | 28,808 | 0 |
| Other Non-Current Assets | 14,578 | 15,724 | 0 |
| TOTAL | $132,089 | $117,109 | $N/A |
| Total Assets | $586,277 | $261,866 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 1,346 | 1,290 | N/A |
| Accounts payable and accrued liabilities | 6,539 | 6,540 | 0 |
| Accrued Expenses | 18,374 | 18,720 | N/A |
| TOTAL | $72,794 | $64,476 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 12,124 | 13,580 | N/A |
| Deferred Revenues | 3,268 | 2,562 | N/A |
| Other Non-Current Liabilities | 40,220 | 40,483 | 0 |
| TOTAL | $52,344 | $54,063 | $N/A |
| Total Liabilities | $125,138 | $118,539 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 104,653 | N/A | N/A |
| Common Shares | 104 | 87 | N/A |
| Retained earnings | 177,369 | 125,076 | N/A |
| Other shareholders' equity | -24,688 | -30,567 | 0 |
| TOTAL | $461,139 | $143,327 | $N/A |
| Total Liabilities And Equity | $586,277 | $261,866 | $0 |